These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 304846)

  • 1. Development and persistence of cytolytic T lymphocytes in regressing or progressing Moloney sarcomas.
    Gillespie GY; Russell SW
    Int J Cancer; 1978 Jan; 21(1):94-99. PubMed ID: 304846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas.
    Gillespie GY; Hansen CB; Hoskins RG; Russell SW
    J Immunol; 1977 Aug; 119(2):564-70. PubMed ID: 301897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of Moloney sarcoma regression or progression.
    Russell SW; Gillespie GY; Hansen CB; Cochrane CG
    Int J Cancer; 1976 Sep; 18(3):331-8. PubMed ID: 1085289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resurgence of killing and in vivo protection mediated by lymphocytes cultured from lymph nodes draining Moloney sarcomas.
    Gillespie GY; Hansen CB; Russell SW
    Br J Cancer; 1978 Sep; 38(3):365-74. PubMed ID: 81673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory cells in solid murine neoplasms. III. Cytotoxicity mediated in vitro by macrophages recovered from disaggregated regressing Moloney sarcomas.
    Russell SW; Gillespie GY; McIntosh AT
    J Immunol; 1977 May; 118(5):1574-9. PubMed ID: 870561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection.
    Lamon EW; Wigzel H; Klein E; Andersson B; Skurzak HM
    J Exp Med; 1973 Jun; 137(6):1472-93. PubMed ID: 4709269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nature, function and distribution of inflammatory cells in regressing and progressing Moloney sarcomas.
    Russell SW; Gillespie GY
    J Reticuloendothel Soc; 1977 Aug; 22(2):159-68. PubMed ID: 72153
    [No Abstract]   [Full Text] [Related]  

  • 9. Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas.
    Russell SW; McIntosh AT
    Nature; 1977 Jul; 268(5615):69-71. PubMed ID: 887150
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostaglandin E2 content of regressing and progressing Moloney sarcomas.
    Wechsler SJ; Eurell TE; Russell SW
    J Leukoc Biol; 1986 Aug; 40(2):159-68. PubMed ID: 3461095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine sarcoma virus (MSV)-induced tumors in mice. I. Distribution of MSV-immune cytolytic T lymphocytes in vivo.
    Plata F; Sordat B
    Int J Cancer; 1977 Feb; 19(2):205-11. PubMed ID: 300075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-T-cell-mediated cytotoxicity in MSV tumor-bearing mice. III. Macrophage-mediated cytotoxicity against autochthonous MSV tumor-isolated target cells.
    Becker S; Haskill S
    Int J Cancer; 1980 Apr; 25(4):535-41. PubMed ID: 6966262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
    Ryser JE; Cerottini JC; Brunner KT
    Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
    Plata F; Cerottini JC; Brunner KT
    Eur J Immunol; 1975 Apr; 5(4):227-33. PubMed ID: 185057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytolytic activity of macrophages isolated from primary murine sarcoma virus (MSV)-induced tumors.
    Taniyama T; Holden HT
    Int J Cancer; 1979 Aug; 24(2):151-60. PubMed ID: 226482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes.
    Leclerc JC; Cantor H
    J Immunol; 1980 Feb; 124(2):846-50. PubMed ID: 6243332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell-mediated immunity to oncornavirus-induced tumors. III. Specific and nonspecific suppression in tumor-bearing mice.
    Plater C; Debré P; Leclerc JC
    Eur J Immunol; 1981 Jan; 11(1):39-44. PubMed ID: 6452278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated cytotoxicity to moloney sarcoma in syngeneic and allogeneic rats.
    Veit BC; Feldman JD
    Int J Cancer; 1975 Mar; 15(3):367-76. PubMed ID: 1079791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors.
    Lamon EW; Anderson B; Wigzell H; Fenyö EM; Klein E
    Int J Cancer; 1974 Jan; 13(1):91-104. PubMed ID: 4594340
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.